The HIF-1α C1772T polymorphism may be associated with susceptibility to clinically localized prostate cancer but not with elevated expression of hypoxic biomarkers

We investigated the role of the C1772T polymorphisms in exon 12 of the Hypoxia-inducible factor-1 alpha (HIF-1α) gene C1772T genotype in prostate cancer (PCa) and amplification of the hypoxic response. We identified the heterozygous germline CT genotype as an increased risk factor for clinically localised prostate cancer (Odds ratio=6.2; p

[1]  M. Coffey,et al.  Hypoxia in prostate cancer: a powerful shield against tumour destruction? , 2008, Cancer treatment reviews.

[2]  M. Thun,et al.  Polymorphisms in Angiogenesis-Related Genes and Prostate Cancer , 2008, Cancer Epidemiology Biomarkers & Prevention.

[3]  C. Ménard,et al.  Androgen withdrawal in patients reduces prostate cancer hypoxia: implications for disease progression and radiation response. , 2007, Cancer research.

[4]  B. Loftus,et al.  In silico mining identifies IGFBP3 as a novel target of methylation in prostate cancer , 2007, British Journal of Cancer.

[5]  Y. Yamabe,et al.  Androgen-Dependent Gene Expression of Prostate-Specific Antigen Is Enhanced Synergistically by Hypoxia in Human Prostate Cancer Cells , 2007, Molecular Cancer Research.

[6]  M. Stampfer,et al.  Hypoxia-inducible factor-1alpha (HIF-1alpha) gene polymorphisms, circulating insulin-like growth factor binding protein (IGFBP)-3 levels and prostate cancer. , 2007, The Prostate.

[7]  A. Orr-Urtreger,et al.  The homozygous P582S mutation in the oxygen‐dependent degradation domain of HIF‐1α is associated with increased risk for prostate cancer , 2007, The Prostate.

[8]  J. Simons,et al.  Hypoxia-inducible factor-1 in human breast and prostate cancer. , 2006, Endocrine-related cancer.

[9]  F. Rojo,et al.  Study of microvessel density and the expression of the angiogenic factors VEGF, bFGF and the receptors Flt-1 and FLK-1 in benign, premalignant and malignant prostate tissues. , 2006, Histology and histopathology.

[10]  J. Mohler,et al.  Hypoxia increases androgen receptor activity in prostate cancer cells. , 2006, Cancer research.

[11]  A. Lazaris,et al.  The expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and angiogenesis markers in hyperplastic and malignant prostate tissue. , 2006, Anticancer research.

[12]  S. Steinberg,et al.  Polymorphism in the hypoxia-inducible factor 1α gene may confer susceptibility to androgen-independent prostate cancer , 2005, Cancer biology & therapy.

[13]  G. Bubley,et al.  Identification of hypoxia-inducible factor-1alpha (HIF-1alpha) polymorphism as a mutation in prostate cancer that prevents normoxia-induced degradation. , 2005, The Prostate.

[14]  G. Semenza,et al.  Up-regulation of hypoxia-inducible factor 1alpha is an early event in prostate carcinogenesis. , 2004, Cancer detection and prevention.

[15]  L. Poellinger,et al.  Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. , 2003, Carcinogenesis.

[16]  C. N. Coleman,et al.  Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  Alexandra L Hanlon,et al.  Hypoxic prostate/muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: preliminary findings. , 2002, Urology.

[18]  L. Salomon,et al.  Human hormone-refractory prostate cancers can harbor mutations in the O(2)-dependent degradation domain of hypoxia inducible factor-1alpha (HIF-1alpha). , 2002, Journal of cancer research and clinical oncology.

[19]  D A Hilton,et al.  Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. , 1999, Cancer research.

[20]  G. Semenza,et al.  Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. , 1999, Annual review of cell and developmental biology.

[21]  D. Bostwick,et al.  Microvessel density in prostate cancer: prognostic and therapeutic utility. , 1998, Seminars in urologic oncology.

[22]  L. Huang,et al.  Regulation of hypoxia-inducible factor 1α is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway , 1998 .

[23]  C. Chresta,et al.  Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. , 1996, Cancer research.